


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app43.us.archive.org';v.server_ms=1214;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>Diagnosis and management of vulvar skin disorders. | National Guideline Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180713072301im_/https://www.guideline.gov/UI/images/favicon-NGC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180713072301im_/https://www.guideline.gov/UI/images/apple-touch-icon-NGC.png">
    <link rel="icon" type="image/png" href="/web/20180713072301im_/https://www.guideline.gov/UI/images/favicon-NGC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180713072301im_/https://www.guideline.gov/UI/images/favicon-NGC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180713072301/https://www.guideline.gov/UI/images/manifest-NGC.json">
    <link rel="mask-icon" href="/web/20180713072301im_/https://www.guideline.gov/UI/images/safari-pinned-tab-NGC.svg" color="#1d4345">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180713072301cs_/https://www.guideline.gov/cassette.axd/stylesheet/8382974d7bae1577062376dcd37102348398fe04/NGCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180713072301js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180713072301if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180713072301/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180713072301if_/https://www.googletagmanager.com/ns.html?id=GTM-KHDP6Z" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180713072301/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KHDP6Z');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180713072301/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180713072301/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180713072301/https://www.guideline.gov/" class="header-logo NGC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180713072301im_/https://www.guideline.gov/UI/images/logo_NGC_header.png">
				        <source srcset="/web/20180713072301im_/https://www.guideline.gov/UI/images/logo_NGC_header_m.png">
				        <img src="/web/20180713072301im_/https://www.guideline.gov/UI/images/logo_NGC_header.png" alt="National Guideline Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180713072301/https://www.guideline.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180713072301/https://www.guideline.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180713072301/https://www.guideline.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NGC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180713072301/https://www.guideline.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180713072301/https://www.guideline.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180713072301/https://www.guideline.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180713072301/https://www.guideline.gov/">Home</a></li>
		        <li class=""><a href="/web/20180713072301/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
		        <li>
<a href="/web/20180713072301/https://www.guideline.gov/summaries/browse" class="parent-link">Guideline Summaries</a>                    		            <ul class="level-2 dropdown">
                             <li class=""><a href="/web/20180713072301/https://www.guideline.gov/browse/clinical-specialty">By Clinical Specialty</a></li>
		                <li class=""><a href="/web/20180713072301/https://www.guideline.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180713072301/https://www.guideline.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180713072301/https://www.guideline.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180713072301/https://www.guideline.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180713072301/https://www.guideline.gov/search?f_DocType=0&amp;fLockTerm=Guideline Summaries">All Summaries</a></li>
		            </ul>
		        </li>
<li class=""><a href="/web/20180713072301/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>		        <li class=""><a href="/web/20180713072301/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180713072301/https://www.guideline.gov/matrix">Matrix Tool</a></li>
		        <li class="">
<a href="/web/20180713072301/https://www.guideline.gov/summaries/submit">Submit Guidelines</a>                    		        </li>
                <li class=""><a href="/web/20180713072301/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our <a href="/web/20180713072301/https://www.guideline.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Guideline Summary</li>
            <li>NGC:006534</li>
            <li>2008 May (reaffirmed 2013)
            </li>            
                                </ul>
        <div>
                <h1>Diagnosis and management of vulvar skin disorders.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180713072301/https://www.guideline.gov/search?f_Guideline_Developer_String=American%20College%20of%20Obstetricians%20and%20Gynecologists&amp;fLockTerm=American%2BCollege%2Bof%2BObstetricians%2Band%2BGynecologists">American College of Obstetricians and Gynecologists</a></li>
                        <li>   
                                <a id="85" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>American College of Obstetricians and Gynecologists (ACOG). Diagnosis and management of vulvar skin disorders. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2008 May. 11 p.&nbsp;(ACOG practice bulletin; no. 93).&nbsp; [90 references]</td></tr></table>            </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>The American College of Obstetricians and Gynecologists (ACOG) reaffirmed the currency of this guideline in 2013.</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
                    <h4>Age Group</h4>
            <ul>
                        <li><a href="/web/20180713072301/https://www.guideline.gov/search?f_Age_of_Target_Population=Aged%2C%2080%20and%20over&amp;fLockTerm=Aged%252c%2B80%2Band%2Bover">Aged, 80 and over</a></li>                      
                        <li><a href="/web/20180713072301/https://www.guideline.gov/search?f_Age_of_Target_Population=Aged%20%2865%20to%2079%20years%29&amp;fLockTerm=Aged%2B%2865%2Bto%2B79%2Byears%29">Aged (65 to 79 years)</a></li>                      
                        <li><a href="/web/20180713072301/https://www.guideline.gov/search?f_Age_of_Target_Population=Middle%20Age%20%2845%20to%2064%20years%29&amp;fLockTerm=Middle%2BAge%2B%2845%2Bto%2B64%2Byears%29">Middle Age (45 to 64 years)</a></li>                      
                        <li><a href="/web/20180713072301/https://www.guideline.gov/search?f_Age_of_Target_Population=Adult%20%2819%20to%2044%20years%29&amp;fLockTerm=Adult%2B%2819%2Bto%2B44%2Byears%29">Adult (19 to 44 years)</a></li>                      
                        <li><a href="/web/20180713072301/https://www.guideline.gov/search?f_Age_of_Target_Population=Adolescent%20%2813%20to%2018%20years%29&amp;fLockTerm=Adolescent%2B%2813%2Bto%2B18%2Byears%29">Adolescent (13 to 18 years)</a></li>                      
                        <li><a href="/web/20180713072301/https://www.guideline.gov/search?f_Age_of_Target_Population=Child%20%282%20to%2012%20years%29&amp;fLockTerm=Child%2B%282%2Bto%2B12%2Byears%29">Child (2 to 12 years)</a></li>                      
            </ul>
                    <h4>UMLS Concepts <a href="/web/20180713072301/https://www.guideline.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180713072301/https://www.guideline.gov/search?f_ICD9CM_CUI=C0156393&amp;fLockTerm=Atrophy+of+vulva">Atrophy of vulva</a>
 (624.1), <a href="/web/20180713072301/https://www.guideline.gov/search?f_ICD9CM_CUI=C0375016&amp;fLockTerm=Human+papillomavirus+in+conditions+classified+elsewhere+and+of+unspecified+site">Human papillomavirus in conditions classified elsewhere and of unspecified site</a>
 (079.4), <a href="/web/20180713072301/https://www.guideline.gov/search?f_ICD9CM_CUI=C0023646&amp;fLockTerm=Lichen+planus">Lichen planus</a>
 (697.0), <a href="/web/20180713072301/https://www.guideline.gov/search?f_ICD9CM_CUI=C0023643&amp;fLockTerm=Lichen%2c+unspecified">Lichen, unspecified</a>
 (697.9), <a href="/web/20180713072301/https://www.guideline.gov/search?f_ICD9CM_CUI=C0023654&amp;fLockTerm=Lichenification+and+lichen+simplex+chronicus">Lichenification and lichen simplex chronicus</a>
 (698.3), <a href="/web/20180713072301/https://www.guideline.gov/search?f_ICD9CM_CUI=C0678202&amp;fLockTerm=Regional+enteritis+of+unspecified+site">Regional enteritis of unspecified site</a>
 (555.9), <a href="/web/20180713072301/https://www.guideline.gov/search?f_ICD9CM_CUI=C0178298&amp;fLockTerm=Unspecified+disorder+of+skin+and+subcutaneous+tissue">Unspecified disorder of skin and subcutaneous tissue</a>
 (709.9), <a href="/web/20180713072301/https://www.guideline.gov/search?f_ICD9CM_CUI=C0156400&amp;fLockTerm=Unspecified+noninflammatory+disorder+of+vulva+and+perineum">Unspecified noninflammatory disorder of vulva and perineum</a>
 (624.9)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0333641&amp;fLockTerm=Atrophy">Atrophy</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0005558&amp;fLockTerm=Biopsy">Biopsy</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0008992&amp;fLockTerm=Clobetasol">Clobetasol</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0010346&amp;fLockTerm=Crohn+Disease">Crohn Disease</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C1449619&amp;fLockTerm=Culture+Techniques">Culture Techniques</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0011603&amp;fLockTerm=Dermatitis">Dermatitis</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0011616&amp;fLockTerm=Dermatitis%2c+Contact">Dermatitis, Contact</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0014939&amp;fLockTerm=Estrogens">Estrogens</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0038902&amp;fLockTerm=Gynecologic+Surgical+Procedures">Gynecologic Surgical Procedures</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0020283&amp;fLockTerm=Hydrogen-Ion+Concentration">Hydrogen-Ion Concentration</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0020517&amp;fLockTerm=Hypersensitivity">Hypersensitivity</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0021079&amp;fLockTerm=Immunosuppression">Immunosuppression</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0023646&amp;fLockTerm=Lichen+Planus">Lichen Planus</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0023652&amp;fLockTerm=Lichen+Sclerosus+et+Atrophicus">Lichen Sclerosus et Atrophicus</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0025084&amp;fLockTerm=Medical+History+Taking">Medical History Taking</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0026018&amp;fLockTerm=Microscopy">Microscopy</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0027822&amp;fLockTerm=Neurodermatitis">Neurodermatitis</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0030186&amp;fLockTerm=Paget+Disease%2c+Extramammary">Paget Disease, Extramammary</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0037274&amp;fLockTerm=Skin+Diseases">Skin Diseases</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0038317&amp;fLockTerm=Steroids">Steroids</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0039601&amp;fLockTerm=Testosterone">Testosterone</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0042239&amp;fLockTerm=Vaginal+Creams%2c+Foams%2c+and+Jellies">Vaginal Creams, Foams, and Jellies</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0042994&amp;fLockTerm=Vulvar+Diseases">Vulvar Diseases</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MSH_CUI=C0022783&amp;fLockTerm=Vulvar+Lichen+Sclerosus">Vulvar Lichen Sclerosus</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0333641&amp;fLockTerm=Atrophic">Atrophic</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0156393&amp;fLockTerm=Atrophy+of+vulva">Atrophy of vulva</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0005558&amp;fLockTerm=Biopsy">Biopsy</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0011616&amp;fLockTerm=Contact+Dermatitis">Contact Dermatitis</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0010346&amp;fLockTerm=Crohn+Disease">Crohn Disease</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C1449619&amp;fLockTerm=Culture+Techniques">Culture Techniques</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0011603&amp;fLockTerm=Dermatitis">Dermatitis</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0037274&amp;fLockTerm=Dermatologic+disorders">Dermatologic disorders</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0950124&amp;fLockTerm=Disease+due+to+Papilloma+virus">Disease due to Papilloma virus</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0014939&amp;fLockTerm=Estrogens">Estrogens</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0375016&amp;fLockTerm=Human+papillomavirus+infection+in+conditions+classified+elsewhere+and+of+unspecified+site">Human papillomavirus infection in conditions classified elsewhere and of unspecified site</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0020283&amp;fLockTerm=Hydrogen-Ion+Concentration">Hydrogen-Ion Concentration</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0020517&amp;fLockTerm=Hypersensitivity">Hypersensitivity</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0023643&amp;fLockTerm=Lichen+disease">Lichen disease</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0023646&amp;fLockTerm=Lichen+Planus">Lichen Planus</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0023654&amp;fLockTerm=Lichenification+and+lichen+simplex+chronicus">Lichenification and lichen simplex chronicus</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0026018&amp;fLockTerm=Microscopy">Microscopy</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0027822&amp;fLockTerm=Neurodermatitis">Neurodermatitis</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0030186&amp;fLockTerm=Paget+Disease+Extramammary">Paget Disease Extramammary</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0678202&amp;fLockTerm=Regional+enteritis">Regional enteritis</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0178298&amp;fLockTerm=Skin+and+subcutaneous+tissue+disorders">Skin and subcutaneous tissue disorders</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0038317&amp;fLockTerm=Steroids">Steroids</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0039601&amp;fLockTerm=Testosterone">Testosterone</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_MTH_CUI=C0021079&amp;fLockTerm=Therapeutic+immunosuppression">Therapeutic immunosuppression</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180713072301/https://www.guideline.gov/search?f_PDQ_CUI=C0005558&amp;fLockTerm=biopsies">biopsies</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_PDQ_CUI=C0021079&amp;fLockTerm=immunosuppression">immunosuppression</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_PDQ_CUI=C0026018&amp;fLockTerm=microscopy">microscopy</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_PDQ_CUI=C1275217&amp;fLockTerm=Paget%27s+disease+of+the+vulva">Paget&#39;s disease of the vulva</a>
, <a href="/web/20180713072301/https://www.guideline.gov/search?f_PDQ_CUI=C0039601&amp;fLockTerm=therapeutic+testosterone">therapeutic testosterone</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0020517&amp;fLockTerm=Allergic+reaction+to+substance">Allergic reaction to substance</a>
 (418634005), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0020517&amp;fLockTerm=Allergic+reaction+to+substance">Allergic reaction to substance</a>
 (421961002), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0455079&amp;fLockTerm=Application+of+moisturizer+to+skin">Application of moisturizer to skin</a>
 (225130001), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0156393&amp;fLockTerm=Atrophic+vulva">Atrophic vulva</a>
 (248861000), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0333641&amp;fLockTerm=Atrophy">Atrophy</a>
 (13331008), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0005558&amp;fLockTerm=Biopsy">Biopsy</a>
 (129314006), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0005558&amp;fLockTerm=Biopsy">Biopsy</a>
 (86273004), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0008992&amp;fLockTerm=Clobetasol">Clobetasol</a>
 (419129004), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0008992&amp;fLockTerm=Clobetasol">Clobetasol</a>
 (48614001), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0011616&amp;fLockTerm=Contact+dermatitis">Contact dermatitis</a>
 (40275004), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0010346&amp;fLockTerm=Crohn%27s+disease">Crohn&#39;s disease</a>
 (34000006), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0950124&amp;fLockTerm=Disease+due+to+Papilloma+virus">Disease due to Papilloma virus</a>
 (30415006), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0037274&amp;fLockTerm=Disorder+of+skin">Disorder of skin</a>
 (95320005), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0178298&amp;fLockTerm=Disorder+of+skin+AND%2fOR+subcutaneous+tissue">Disorder of skin AND/OR subcutaneous tissue</a>
 (80659006), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0042994&amp;fLockTerm=Disorder+of+vulva">Disorder of vulva</a>
 (5089007), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0014939&amp;fLockTerm=Estrogen">Estrogen</a>
 (41598000), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0014939&amp;fLockTerm=Estrogen">Estrogen</a>
 (61946003), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0020283&amp;fLockTerm=Hydrogen+ion+concentration">Hydrogen ion concentration</a>
 (27327002), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0021079&amp;fLockTerm=Immunosuppressive+therapy">Immunosuppressive therapy</a>
 (86553008), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0023643&amp;fLockTerm=Lichen">Lichen</a>
 (88996004), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0023646&amp;fLockTerm=Lichen+planus">Lichen planus</a>
 (4776004), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0023652&amp;fLockTerm=Lichen+sclerosus+et+atrophicus">Lichen sclerosus et atrophicus</a>
 (25674000), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0022783&amp;fLockTerm=Lichen+sclerosus+et+atrophicus+of+the+vulva">Lichen sclerosus et atrophicus of the vulva</a>
 (198380007), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0022783&amp;fLockTerm=Lichen+sclerosus+et+atrophicus+of+the+vulva">Lichen sclerosus et atrophicus of the vulva</a>
 (26348009), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0023654&amp;fLockTerm=Lichenification+and+lichen+simplex+chronicus">Lichenification and lichen simplex chronicus</a>
 (201020007), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0026018&amp;fLockTerm=Microscopy">Microscopy</a>
 (117259009), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0027822&amp;fLockTerm=Neurodermatitis">Neurodermatitis</a>
 (267854005), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0038902&amp;fLockTerm=Operation+on+female+genital+organs">Operation on female genital organs</a>
 (12658000), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0030186&amp;fLockTerm=Paget%27s+disease+of+skin">Paget&#39;s disease of skin</a>
 (232336001), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0030186&amp;fLockTerm=Paget%27s+disease+of+skin">Paget&#39;s disease of skin</a>
 (71447003), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1275217&amp;fLockTerm=Paget%27s+disease+of+vulva">Paget&#39;s disease of vulva</a>
 (254898001), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0038317&amp;fLockTerm=Steroid">Steroid</a>
 (116566001), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0039601&amp;fLockTerm=Testosterone">Testosterone</a>
 (109033004), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0039601&amp;fLockTerm=Testosterone">Testosterone</a>
 (43688007), <a href="/web/20180713072301/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0429263&amp;fLockTerm=Vaginal+pH">Vaginal pH</a>
 (251425002)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#420" class="section-mark">Recommendations</a></li>
                                    <li><a href="#396" class="section-mark">Scope</a></li>
                                    <li><a href="#405" class="section-mark">Methodology</a></li>
                                    <li><a href="#424" class="section-mark">Evidence Supporting the Recommendations</a></li>
                                    <li><a href="#427" class="section-mark">Benefits/Harms of Implementing the Guideline Recommendations</a></li>
                                    <li><a href="#432" class="section-mark">Qualifying Statements</a></li>
                                    <li><a href="#434" class="section-mark">Implementation of the Guideline</a></li>
                                    <li><a href="#439" class="section-mark">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></li>
                                    <li><a href="#442" class="section-mark">Identifying Information and Availability</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180713072301/https://www.guideline.gov/summaries/downloadcontent/ngc-6534?contentType=pdf" class="pdf">.PDF 80.2 kb</a></li>
                            <li><a href="/web/20180713072301/https://www.guideline.gov/summaries/downloadcontent/ngc-6534?contentType=word" class="word">Word Document 272.2 kb</a></li>
                            <li><a href="/web/20180713072301/https://www.guideline.gov/summaries/downloadcontent/ngc-6534?contentType=xml" class="xml">.XML 25 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180713072301/https://www.facebook.com/sharer/sharer.php?u=https://www.guideline.gov/summaries/summary/12626/diagnosis-and-management-of-vulvar-skin-disorders" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180713072301/https://twitter.com/share?text=&amp;url=https://www.guideline.gov/summaries/summary/12626/diagnosis-and-management-of-vulvar-skin-disorders" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180713072301/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.guideline.gov/summaries/summary/12626/diagnosis-and-management-of-vulvar-skin-disorders&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180713072301/mailto:/?Subject=AHRQ: Diagnosis and management of vulvar skin disorders.&amp;body=https://www.guideline.gov/summaries/summary/12626/diagnosis-and-management-of-vulvar-skin-disorders" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Guideline Clearinghouse (NGC). Guideline summary: Diagnosis and management of vulvar skin disorders. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2008 May 01. [cited 2018 Jul 13]. Available: https://www.guideline.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180713072301/https://www.guideline.gov/summaries/citedownload/12626?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180713072301/https://www.guideline.gov/summaries/citedownload/12626?format=enw">EndNote</a></li>
                            <li><a href="/web/20180713072301/https://www.guideline.gov/summaries/citedownload/12626?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180713072301/https://www.guideline.gov/summaries/citedownload/12626?format=txt">Medlars</a></li>
                            <li><a href="/web/20180713072301/https://www.guideline.gov/summaries/citedownload/12626?format=ris">ProCite</a></li>
                            <li><a href="/web/20180713072301/https://www.guideline.gov/summaries/citedownload/12626">RefWorks</a></li>
                            <li><a href="/web/20180713072301/https://www.guideline.gov/summaries/citedownload/12626?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="12626" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="420" class="accordion-title section-420 is-active" role="tab" aria-expanded="true"><a href="#">Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Major Recommendations</a></h3>
                    <p><div class="content_para"><p>The grades of evidence (I-III) and levels of recommendation (A-C) are defined at the end of the &quot;Major Recommendations&quot; field.</p>

<p><strong>The following recommendation is based on limited or inconsistent scientific evidence (Level B)</strong>:</p>

<ul type="disc">
<li>The recommended treatment for lichen sclerosus is an ultrapotent topical corticosteroid, such as clobetasol propionate.</li></ul>

<p><strong>The following recommendations are based primarily on consensus and expert opinion (Level C)</strong>:</p>

<ul type="disc">
<li>Biopsy of hyperpigmented or exophytic lesions, lesions with changes in vascular patterns, or unresolving lesions is particularly important and should be performed to rule out carcinoma.</li>

<li>For patients with biopsy-confirmed Paget disease, further evaluation of the breast, genitourinary tract, and gastrointestinal tract should be undertaken.</li></ul>

<p><strong><u>Definitions</u></strong><u>:</u></p>

<p><strong>Grades of Evidence</strong></p>

<p><strong>I</strong> Evidence obtained from at least one properly designed randomized controlled trial.</p>

<p><strong>II-1</strong> Evidence obtained from well-designed controlled trials without randomization.</p>

<p><strong>II-2</strong> Evidence obtained from well-designed cohort or case&#8211;control analytic studies, preferably from more than one center or research group.</p>

<p><strong>II-3</strong> Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments also could be regarded as this type of evidence.</p>

<p><strong>III</strong> Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees.</p>

<p><strong>Levels of Recommendation</strong></p>

<p><strong>Level A</strong> &#8212; Recommendations are based on good and consistent scientific evidence.</p>

<p><strong>Level B</strong> &#8212; Recommendations are based on limited or inconsistent scientific evidence.</p>

<p><strong>Level C</strong> &#8212; Recommendations are based primarily on consensus and expert opinion.</p></div></p>
                        <h3><a href="#">Clinical Algorithm(s)</a></h3>
                    <p><div class="content_para"><p>None provided</p></div></p>

            </div>
                <h2 id="396" class="accordion-title section-396 is-active" role="tab" aria-expanded="true"><a href="#">Scope</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Disease/Condition(s)</a></h3>
                    <p><div class="content_para"><p>Vulvar skin disorders, including:</p>

<ul type="disc">
<li>Vulvar dermatoses: contact dermatitis, lichen simplex chronicus, lichen sclerosus, lichen planus</li>
<li>Vulvar atrophy</li>
<li>Genital human papillomavirus (HPV) infection</li>
<li>Paget disease</li>
<li>Crohn's disease</li></ul></div></p>
                        <h3><a href="#">Guideline Category</a></h3>
                    <p>Diagnosis</p>
                    <p>Evaluation</p>
                    <p>Management</p>
                    <p>Treatment</p>
                        <h3><a href="#">Clinical Specialty</a></h3>
                    <p>Family Practice</p>
                    <p>Infectious Diseases</p>
                    <p>Obstetrics and Gynecology</p>
                    <p>Pediatrics</p>
                        <h3><a href="#">Intended Users</a></h3>
                    <p>Physicians</p>
                        <h3><a href="#">Guideline Objective(s)</a></h3>
                    <p><ul type="disc">
<li>To aid practitioners in making decisions about appropriate obstetric and gynecologic care</li>
<li>To review diagnostic approaches and provide a structured framework for the management of vulvar disorders</li></ul></p>
                        <h3><a href="#">Target Population</a></h3>
                    <p><div class="content_para"><p>Women and female children and adolescents with symptoms of vulvar disorders</p></div></p>
                        <h3><a href="#">Interventions and Practices Considered</a></h3>
                    <p><div class="content_para"><p><strong>Evaluation and Diagnosis</strong></p>

<ol start="1" type="1">
<li>Evaluation of signs and symptoms (e.g., vulvar pain, pruritus)</li>
<li>Medical history</li>
<li>Search for common vulvar irritants and allergens</li>
<li>Vulvar biopsy</li>
<li>Additional diagnostic tests (e.g., culture, microscopy, vaginal pH)</li></ol>

<p><strong>Treatment and Management</strong></p>

<ol start="1" type="1">
<li>Topical therapies

<ul type="disc">
<li>Estrogen and testosterone creams</li>
<li>Topical steroid cream (clobetasol propionate)</li>
<li>Nonhormonal vaginal moisturizer</li></ul>
</li>

<li>Systemic immunosuppressive therapies</li>
<li>Surgery</li>
<li>Further evaluation of biopsy-confirmed Paget disease</li></ol></div></p>
                        <h3><a href="#">Major Outcomes Considered</a></h3>
                    <p><ul type="disc">
<li>Symptom relief</li>
<li>Sexual function</li>
<li>Well-being</li></ul></p>

            </div>
                <h2 id="405" class="accordion-title section-405 is-active" role="tab" aria-expanded="true"><a href="#">Methodology</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Methods Used to Collect/Select the Evidence</a></h3>
                    <p>Hand-searches of Published Literature (Primary Sources)</p>
                    <p>Hand-searches of Published Literature (Secondary Sources)</p>
                    <p>Searches of Electronic Databases</p>
                        <h3><a href="#">Description of Methods Used to Collect/Select the Evidence</a></h3>
                    <p><div class="content_para"><p><strong>2008 Guideline</strong></p>
<p>The MEDLINE database, the Cochrane Library, and the American College of Obstetricians and Gynecologists' own internal resources and documents were used to conduct a literature search to locate relevant articles published between January 1985 and August 2007. The search was restricted to articles published in the English language. Priority was given to articles reporting results of original research, although review articles and commentaries also were consulted. Abstracts of research presented at symposia and scientific conferences were not considered adequate for inclusion in this document. Guidelines published by organizations or institutions such as the National Institutes of Health and the American College of Obstetricians and Gynecologists were reviewed, and additional studies were located by reviewing bibliographies of identified articles.</p>
<p><strong>2013 Reaffirmation</strong></p>
<p>The NCBI database was searched from 2008 to 2013. Committee members conducted a literature search with the assistance from the ACOG Resource Center staff who routinely perform the Practice Bulletin literature searches.</p></div></p>
                        <h3><a href="#">Number of Source Documents</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Methods Used to Assess the Quality and Strength of the Evidence</a></h3>
                    <p>Weighting According to a Rating Scheme (Scheme Given)</p>
                        <h3><a href="#">Rating Scheme for the Strength of the Evidence</a></h3>
                    <p><div class="content_para"><p>Studies were reviewed and evaluated for quality according to the method outlined by the U.S. Preventive Services Task Force:</p>

<p><strong>I</strong> Evidence obtained from at least one properly designed randomized controlled trial.</p>

<p><strong>II-1</strong> Evidence obtained from well-designed controlled trials without randomization.</p>

<p><strong>II-2</strong> Evidence obtained from well-designed cohort or case&#8211;control analytic studies, preferably from more than one center or research group.</p>

<p><strong>II-3</strong> Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments also could be regarded as this type of evidence.</p>

<p><strong>III</strong> Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees.</p></div></p>
                        <h3><a href="#">Methods Used to Analyze the Evidence</a></h3>
                    <p>Review of Published Meta-Analyses</p>
                    <p>Systematic Review</p>
                        <h3><a href="#">Description of the Methods Used to Analyze the Evidence</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Methods Used to Formulate the Recommendations</a></h3>
                    <p>Expert Consensus</p>
                        <h3><a href="#">Description of Methods Used to Formulate the Recommendations</a></h3>
                    <p><div class="content_para"><p><strong>2008 Guideline</strong></p>
<p>Analysis of available evidence was given priority in formulating recommendations. When reliable research was not available, expert opinions from obstetrician&ndash;gynecologists were used. See also the "Rating Scheme for the Strength of Recommendations" field regarding Grade C recommendations.</p>
<p><strong>2013 Reaffirmation</strong></p>
<p>The Committee on Practice Bulletins - Gynecology met in March 2013 and reaffirmed this document. A committee member reviewed the document and new literature on the topic. The document was then reviewed by the committee and the committee agreed that it is current and accurate.</p></div></p>
                        <h3><a href="#">Rating Scheme for the Strength of the Recommendations</a></h3>
                    <p><div class="content_para"><p>Based on the highest level of evidence found in the data, recommendations are provided and graded according to the following categories:</p>

<p><strong>Level A</strong> &#8212; Recommendations are based on good and consistent scientific evidence.</p>

<p><strong>Level B</strong> &#8212; Recommendations are based on limited or inconsistent scientific evidence.</p>

<p><strong>Level C</strong> &#8212; Recommendations are based primarily on consensus and expert opinion.</p></div></p>
                        <h3><a href="#">Cost Analysis</a></h3>
                    <p><div class="content_para"><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div></p>
                        <h3><a href="#">Method of Guideline Validation</a></h3>
                    <p>Internal Peer Review</p>
                        <h3><a href="#">Description of Method of Guideline Validation</a></h3>
                    <p><div class="content_para"><p>Practice Bulletins are validated by two internal clinical review panels composed of practicing obstetrician-gynecologists generalists and sub-specialists. The final guidelines are also reviewed and approved by the American College of Obstetricians and Gynecologists (ACOG) Executive Board.</p></div></p>

            </div>
                <h2 id="424" class="accordion-title section-424 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Recommendations</a></h3>
                    <p><div class="content_para"><p>The type of supporting evidence is identified and graded for each recommendation (see &quot;Major Recommendations&quot;).</p></div></p>

            </div>
                <h2 id="427" class="accordion-title section-427 is-active" role="tab" aria-expanded="true"><a href="#">Benefits/Harms of Implementing the Guideline Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Potential Benefits</a></h3>
                    <p><div class="content_para"><p>Accurate diagnosis and appropriate management of vulvar skin disorders</p></div></p>
                        <h3><a href="#">Potential Harms</a></h3>
                    <p><ul type="disc">
<li>Side effects of:

<ul type="disc">
<li>Topical estrogen therapy in girls</li>
<li>Topical steroid therapy</li>
<li>Systemic immunosuppressants</li></ul>
</li>

<li>When compared in randomized controlled trials with either estrogen tablets or with the estrogen ring, conjugated equine estrogen cream was found to be significantly associated with adverse effects, including bleeding, breast pain, and perineal pain.</li>

<li>All forms of topical estrogen therapy increase the possibility of endometrial hyperplasia and overstimulation.</li></ul></p>

            </div>
                <h2 id="432" class="accordion-title section-432 is-active" role="tab" aria-expanded="true"><a href="#">Qualifying Statements</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Qualifying Statements</a></h3>
                    <p><div class="content_para"><p>These guidelines should not be construed as dictating an exclusive course of treatment or procedure. Variations in practice may be warranted based on the needs of the individual patient, resources, and limitations unique to the institution or type of practice.</p></div></p>

            </div>
                <h2 id="434" class="accordion-title section-434 is-active" role="tab" aria-expanded="true"><a href="#">Implementation of the Guideline</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description of Implementation Strategy</a></h3>
                    <p><div class="content_para"><p>An implementation strategy was not provided.</p></div></p>
                        <h3><a href="#">Implementation Tools</a></h3>
                    <p>Audit Criteria/Indicators</p>
                    <p><div class="general-block">For information about availability, see the <i>Availability of Companion Documents</i> and <i>Patient Resources</i> fields below.</div></p>

            </div>
                <h2 id="439" class="accordion-title section-439 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Getting Better</p>
                    <p>Living with Illness</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>
                    <p>Patient-centeredness</p>

            </div>
                <h2 id="442" class="accordion-title section-442 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information and Availability</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Bibliographic Source(s)</a></h3>
                    <p><table><tr><td>American College of Obstetricians and Gynecologists (ACOG). Diagnosis and management of vulvar skin disorders. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2008 May. 11 p.&nbsp;(ACOG practice bulletin; no. 93).&nbsp; [90 references]</td></tr></table></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date Released</a></h3>
                    <p>2008 May (reaffirmed 2013)</p>
                        <h3><a href="#">Guideline Developer(s)</a></h3>
                    <p>American College of Obstetricians and Gynecologists - Medical Specialty Society</p>
                        <h3><a href="#">Source(s) of Funding</a></h3>
                    <p><div class="content_para"><p>American College of Obstetricians and Gynecologists (ACOG)</p></div></p>
                        <h3><a href="#">Guideline Committee</a></h3>
                    <p><div class="content_para"><p>American College of Obstetricians and Gynecologists (ACOG) Committee on Practice Bulletins - Gynecology</p></div></p>
                        <h3><a href="#">Composition of Group That Authored the Guideline</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Financial Disclosures/Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Guideline Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>The American College of Obstetricians and Gynecologists (ACOG) reaffirmed the currency of this guideline in 2013.</p></div></p>
                        <h3><a href="#">Guideline Availability</a></h3>
                    <p><div class="content_para"><p>No electronic copies available</p>
<p>Print copies: Available for purchase from the American College of Obstetricians and Gynecologists (ACOG) Distribution Center, PO Box 933104, Atlanta, GA 31193-3104; telephone, 800-762-2264, ext. 192; e-mail: <a href="https://web.archive.org/web/20180713072301/mailto:sales@acog.org">sales@acog.org</a>. The ACOG Bookstore is available online at the <a href="/web/20180713072301/https://www.guideline.gov/Home/Disclaimer?id=12626&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acog.org%2fbookstore%2f" target="_blank" title="ACOG Web site">ACOG Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713072301im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">Availability of Companion Documents</a></h3>
                    <p><div class="content_para"><p>Proposed performance measures are included in the original guideline document.</p></div></p>
                        <h3><a href="#">Patient Resources</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">NGC Status</a></h3>
                    <p><div class="content_para"><p>This NGC summary was completed by ECRI Institute on July 29, 2008. The information was verified by the guideline developer on August 20, 2008. This summary was updated by ECRI Institute on August 18, 2009, following the revised FDA advisory on CellCept (mycophenolate mofetil). The currency of the guideline was reaffirmed by the developer in 2013 and this summary was updated by ECRI Institute on March 7, 2014.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NGC Disclaimer</a></h3>
                    <p><p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/web/20180713072301/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NGC Guideline Summaries</h3>
            <p>NGC provides structured summaries containing information from clinical practice guidelines.</p>
            <ul>
                <li><a href="/web/20180713072301/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180713072301/https://www.guideline.gov/help-and-about/summaries/template-of-guideline-attributes" class="internal-link">Template of Guideline Attributes</a></li>
                <li><a href="/web/20180713072301/https://www.guideline.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180713072301/https://www.guideline.gov/help-and-about/summaries/faqs" class="help-button">Guideline Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NGC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180713072301/https://www.guideline.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180713072301/https://www.guideline.gov/rssFiles/ngc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon guideline news-list-category-label">Guideline Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011378</li>
            <li>2017 Oct</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180713072301/https://www.guideline.gov/summaries/summary/51300/mental-health-care-in-the-perinatal-period-australian-clinical-practice-guideline">Mental health care in the perinatal period: Australian clinical practice guideline.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011372</li>
            <li>2015</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180713072301/https://www.guideline.gov/summaries/summary/51294/clinical-practice-guideline-on-systemic-lupus-erythematosus">Clinical practice guideline on systemic lupus erythematosus.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011385</li>
            <li>2018 Mar</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180713072301/https://www.guideline.gov/summaries/summary/51326/vadod-clinical-practice-guideline-for-the-management-of-pregnancy">VA/DoD clinical practice guideline for the management of pregnancy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011376</li>
            <li>2018 Feb</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180713072301/https://www.guideline.gov/summaries/summary/51298/clinical-pharmacogenetics-implementation-consortium-cpic-guideline-for-dihydropyrimidine-dehydrogenase-genotype-and-fluoropyrimidine-dosing-2017-update">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011370</li>
            <li>2017 Dec</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180713072301/https://www.guideline.gov/summaries/summary/51292/the-implementation-of-targeted-temperature-management-an-evidencebased-guideline-from-the-neurocritical-care-society">The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society.</a></p>
    </div>

    <a class="block-link" href="/web/20180713072301/https://www.guideline.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180713072301/https://www.guideline.gov/disclaimer?id=12626&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180713072301im_/https://www.guideline.gov/UI/images/logo_NGC_footer.svg">
					  	<img src="/web/20180713072301im_/https://www.guideline.gov/UI/images/logo_NGC_footer.png" alt="NGC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180713072301/https://www.guideline.gov/">Home</a></li>
		                <li><a href="/web/20180713072301/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180713072301/https://www.guideline.gov/browse/organization" class="parent-link">Guideline Summaries</a></li>
<li><a href="/web/20180713072301/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>						<li><a href="/web/20180713072301/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180713072301/https://www.guideline.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180713072301/https://www.guideline.gov/summaries/submit">Submit Guidelines</a></li>
						<li><a href="/web/20180713072301/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180713072301/https://www.guideline.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180713072301/https://www.guideline.gov/rss">RSS</a></li>
					    <li><a href="/web/20180713072301/https://www.guideline.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180713072301/https://www.guideline.gov/browse/related">Related NQMC Measures</a></li>
                        <li><a href="/web/20180713072301/https://www.guideline.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180713072301/https://www.guideline.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180713072301/https://www.guideline.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180713072301/https://www.guideline.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180713072301/https://www.guideline.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180713072301/https://www.guideline.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
				    <li><!-- NQMC footer link -->
						<a href="https://web.archive.org/web/20180713072301/https://www.qualitymeasures.ahrq.gov/" target="_blank" class="partner-button nqmc">
							<span class="partner-logo">
								<picture>
							    	<source type="image/svg+xml" srcset="/web/20180713072301im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.svg">
									<img src="/web/20180713072301im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.png" alt="National Quality Measures Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/MQMC footer Link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180713072301/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180713072301im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180713072301im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180713072301/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180713072301/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180713072301js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180713072301js_/https://www.guideline.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 07:23:01 Jul 13, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 17:05:19 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 1120.772 (3)
  esindex: 0.01
  captures_list: 1142.25
  CDXLines.iter: 15.17 (3)
  PetaboxLoader3.datanode: 93.036 (4)
  exclusion.robots: 0.291
  exclusion.robots.policy: 0.272
  RedisCDXSource: 1.707
  PetaboxLoader3.resolve: 1033.303 (3)
  load_resource: 28.743
-->